{
    "symbol": "EVGN",
    "quarter": 1,
    "year": 2022,
    "date": "2022-05-27 14:07:09",
    "content": " For example, Evogene is using forward-looking statements in this call when it discusses expected path to value creation, including potential fundraising at the subsidiary level and untapping value in its subsidiaries, its and its' subsidiaries expected trials and their expected results, studies, product advancements, commercialization, launches, pipelines, milestones, potential collaborations, target markets and other plans for 2022 and beyond, expected cash burn rate, the potential advantages of its technology and its anticipated entry into new fields of activity."
}